Angie You - 20 Jun 2025 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
20 Jun 2025
Net transactions value
+$262,899
Form type
4
Filing time
23 Jun 2025, 20:05:17 UTC
Previous filing
06 Jan 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
You Angie Director C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO /s/ Christian Kuhlen, attorney-in-fact 23 Jun 2025 0001647664

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Purchase $249,669 +26,597 $9.39 26,597 20 Jun 2025 Direct F1
transaction ORIC Common Stock Purchase $13,230 +1,403 +5.3% $9.43 28,000 23 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 26,597 shares purchased in the price range of $9.14 to $9.50 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.